This site is intended for healthcare professionals

Scilex Holding /Sorrento Therapeutics has received a sNDA approval from the FDA for ZTlido to make efficacy labeling change with clinical data for post-herpetic neuralgia.

Read time: 1 mins
Last updated:11th Apr 2021
Published:11th Apr 2021
Condition: Pain: Post Herpetic Neuralgia
Type: drug
Register for free access to this exclusive healthcare learning resource

Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest